Method of purifying a biological material of interest in a sample using nanofiber ultrafiltration membranes operated in tangential flow filtration mode

US10675588B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10675588-B2
Application numberUS-201615561579-A
CountryUS
Kind codeB2
Filing dateFeb 17, 2016
Priority dateApr 17, 2015
Publication dateJun 9, 2020
Grant dateJun 9, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments described herein relate to electrospun nanofiber ultrafiltration membrane compositions capable of operating in tangential filtration mode and methods of using the same.

First claim

Opening claim text (preview).

What is claimed is: 1. Method of purifying a biological material of interest in a sample comprising: a. providing a sample containing the biological material of interest having a molecular weight equal to or greater than 500 K Da, wherein the biological material of interest is selected from a therapeutic protein, a conjugated polysaccharide vaccine and a virus-like particle; b. contacting the sample in tangential filtration (TFF) mode with an electrospun nanofiber membrane composition comprising nylon nanofibers having an average fiber diameter less than 15 nm, thereby resulting in a permeate and a retentate; and c. collecting the retentate containing the biological material of interest, thereby purifying the biological material of interest. 2. The method of claim 1 , wherein the method results in an increase in the concentration of the biological material of interest. 3. The method of claim 1 , wherein the electrospun nanofiber composition exhibits a higher water permeability in TFF mode compared to a solution cast polymeric membrane. 4. The method of claim 1 , wherein the electrospun nanofiber membrane composition exhibits a higher flux in TFF mode compared to a solution cast polymeric membrane. 5. The method of claim 1 , wherein the collecting step comprises diafiltration. 6. The method of claim 1 , wherein the electrospun nanofiber membrane composition is made from Nylon-6. 7. The method of claim 1 , wherein the purified biological material of interest has a 90% yield or greater than 90% yield. 8. The method of claim 1 , wherein the electrospun nanofiber membrane composition is incorporated into a device suitable for TFF. 9. The method of claim 8 , wherein the device is a cassette or a spiral wound device.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10675588B2 cover?
Embodiments described herein relate to electrospun nanofiber ultrafiltration membrane compositions capable of operating in tangential filtration mode and methods of using the same.
Who is the assignee on this patent?
Emd Millipore Corp
What technology area does this patent fall under?
Primary CPC classification B01D61/145. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).